Survival of BRCA2-Deficient Cells Is Promoted by GIPC3, a Novel Genetic Interactor of BRCA2

BRCA2 loss-of-heterozygosity (LOH) is frequently observed in BRCA2-mutated tumors, but its biallelic loss causes embryonic lethality in mice and inhibits proliferation of normal somatic cells. Therefore, it remains unclear how loss of BRCA2 contributes to tumorigenesis. One possibility is that mutat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Genetics
Hlavní autoři: Ding, Xia, Philip, Subha, Martin, Betty K., Pang, Yan, Burkett, Sandra, Swing, Deborah A., Pamala, Chinmayi, Ritt, Daniel A., Zhou, Ming, Morrison, Deborah K., Ji, Xinhua, Sharan, Shyam K.
Médium: Artigo
Jazyk:Inglês
Vydáno: Genetics Society of America 2017
Témata:
Investigations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5714451/
https://ncbi.nlm.nih.gov/pubmed/29021281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1534/genetics.117.300357
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky